Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Liothyronine sodium |
| Synonyms | |
| Therapy Description |
Triostat (liothyronine sodium) is a synthetic version of T3, which induces thyroid hormone responsive gene expression to promote normal development and growth (NCI Drug DIctionary). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Liothyronine sodium | Triostat | Cytomel | Triostat (liothyronine sodium) is a synthetic version of T3, which induces thyroid hormone responsive gene expression to promote normal development and growth (NCI Drug DIctionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT01182285 | Phase II | Liothyronine sodium Valproic acid | A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell Origin | Completed | USA | 0 |